• No results found

18 results with keyword: 'future glucose lowering drugs for type diabetes'

Future glucose-lowering drugs for type 2 diabetes

Plasma concentrations of FGF21 are raised in obesity and type 2 diabetes, possibly due to FGF21 resistance, and preliminary animal and human studies suggest that administration

Protected

N/A

10
0
0
2021
Glucose-lowering medicines for type 2 diabetes

Suggested uses • Clear symptoms of insulin deficiency • Failure of oral agents • Metformin intolerance • Alternate to sulphonylurea if metformin- sulphonylura combination

Protected

N/A

5
0
0
2021
Understanding Your Diabetes HELPLINE:

• Type 2 diabetes can sometimes be treated with diet and exercise alone, sometimes with oral blood glucose lowering drugs and if this fails to reduce blood glucose

Protected

N/A

28
0
0
2021
Once-Weekly Glucose-Lowering Therapy for Type 2 Diabetes

controlled trials, weight loss with exenatide QW treatment was similar to that of exenatide twice daily or metformin; significantly greater than that of sitagliptin,

Protected

N/A

6
0
0
2020
Sitagliptin for Elderly Patients Aged 75 Years or Older with Inadequately Controlled Type 2 Diabetes with Common Antidiabetes Treatments

The present study shows that sitagliptin added to existing glucose-lowering drugs is well tolerated, weight- neutral, and improves glycemic control in patients with type 2

Protected

N/A

10
0
0
2020
How To Improve Glycaemic Control

• In this observational study of people with type 2 diabetes with suboptimal glycaemic control using oral glucose-lowering drugs and ⁄ or lifestyle therapy, significant improvements

Protected

N/A

10
0
0
2021
Effect of different methods for estimating persistence and adherence to new glucose-lowering drugs: results of an observational, inception cohort study in Portugal

We estimated persistence and adherence levels to new glucose-lowering drugs (GLDs) in type 2 diabetes mellitus (T2DM) patients using different methods: through the collection of

Protected

N/A

12
0
0
2020
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes

Abstract: Type 2 diabetes carries a risk for hypoglycemia, particularly in patients on an intensive glucose control plan as a glucose-lowering strategy, where

Protected

N/A

9
0
0
2020
Chick Corea Collection

The album, along with its counterpart Piano Improvisations Vol. 1, was recorded over the course of two days in Oslo, Norway. The two albums in the Piano Improvisations series serve as

Protected

N/A

195
0
0
2021
Am I at risk for type 2 diabetes?

Even though controlling your weight with lifestyle changes is challenging, it produces long-term health rewards by lowering your risk for type 2 diabetes, lowering your blood

Protected

N/A

39
0
0
2021
Disaster Risk Reduction and Climate Change Adaptation—A Sustainable Development Systems Perspective

Several key points in this part are: (1) One may accomplish disaster risk reduction which in the medium to long run is not sustainable in terms of ecological, economic,

Protected

N/A

15
0
0
2020
Glucose-lowering therapies in type 2 diabetes: Opportunities and challenges for peptides

The balance of activities requires the glucose-lowering effect of GLP-1 to predominate over the potential for glucagon to raise blood glucose, while effects mediated through

Protected

N/A

24
0
0
2021
Insulin Resistance and Prediabetes

Even though controlling weight with lifestyle changes is challenging, it produces long- term health rewards by lowering the risk for type 2 diabetes, lowering blood glucose

Protected

N/A

20
0
0
2022
Insulin and Other Glucose-Lowering Drugs

These agents are useful in the treatment of patients who have type 2 diabetes but who cannot be managed by diet alone. Patients who have developed diabetes after age

Protected

N/A

11
0
0
2021
Comparison of the effectiveness of different oral glucose lowering drugs in fasting patients with type II diabetes

Also Sulfonylurea dose reduction, in the diabetic patients during fasting, does not cause significant differences in reducing hypoglycemia risk; and on the other hand,

Protected

N/A

8
0
0
2020
PRIVATE ISLAND RENTAL. Your home away from home

Full Island buyout nightly rates start from US$36,300 (rate varies, subject to seasonality), inclusive of speedboat transfers from the international airport in Malé for all

Protected

N/A

11
0
0
2022
Nursing home patients with diabetes: Prevalence, drug treatment and glycemic control

This study aims to determine the prevalence of diabetes in Norwegian nursing homes, and investigate the use of blood glucose lowering drugs, frequency of capillary blood

Protected

N/A

8
0
0
2021
The Relationship Between Educational Support and Entrepreneurial Intentions in Malaysian Higher Learning Institution

p< 0.05 ATTITUDINAL FACTORS PERSONALITY TRAITS CURIOSITY LOCUS OF CONTROL H 1 H3 INTENTION TO BE AN ENTREPRENEUR H 2 BEHAVIOURIAL FACTORS CREATIVITY RISK

Protected

N/A

10
0
0
2021

Upload more documents and download any material studies right away!